Patient-or Physician-Oriented Marketing: What Drives Primary Demand for Prescription Drugs?

The authors analyze primary demand effects of marketing efforts directed at the physician (detailing and professional journal advertising) versus marketing efforts directed at the patient (direct-to-consumer advertising). The analysis covers 86 categories, or approximately 85% of the U.S. pharmaceutical market, during the 2001–2005 period. Primary demand effects are rather small, in contrast with the estimated sales effects for individual brands. By using a new brand-level method to estimate primary demand effects with aggregate data, the authors show that the small effects are due to intense competitive interactions during the observation period but not necessarily to low primary demand responsiveness. In contrast with previous studies, the authors also find that detailing is more effective in driving primary demand than direct-to-consumer advertising. A category sales model cannot provide such insights. In addition, a category sales model likely produces biased predictions about period-by-period changes in primary demand. The suggested brand-level method does not suffer from these limitations.

[1]  Dominique M. Hanssens,et al.  Market Response Models: Econometric and Time Series Analysis , 1989 .

[2]  Gerard J. Tellis,et al.  An Analysis of the Tradeoff between Advertising and Price Discounting , 1991 .

[3]  Pradeep Chintagunta,et al.  Beyond the Endogeneity Bias: The Effect of Unmeasured Brand Characteristics on Household-Level Brand Choice Models , 2005, Manag. Sci..

[4]  Michaela D. Platzer,et al.  Market Response Models , 2002 .

[5]  W. Greene,et al.  计量经济分析 = Econometric analysis , 2009 .

[6]  S. Wolfe Direct-to-consumer advertising--education or emotion promotion? , 2002, The New England journal of medicine.

[7]  Z. Griliches,et al.  Characteristics of demand for pharmaceutical products: an examination of four cephalosporins. , 1997, The Rand journal of economics.

[8]  Sridhar Narayanan,et al.  Return on Investment Implications for Pharmaceutical Promotional Expenditures: The Role of Marketing-Mix Interactions , 2004 .

[9]  Harikesh S. Nair,et al.  Accounting for Primary and Secondary Demand Effects with Aggregate Data , 2004 .

[10]  Stan Hurn Panel Data Econometrics , 2010 .

[11]  Carl F. Mela,et al.  The Dynamic Effect of Innovation on Market Structure , 2004 .

[12]  Jonathan H. Wright,et al.  A Survey of Weak Instruments and Weak Identification in Generalized Method of Moments , 2002 .

[13]  Greg M. Allenby,et al.  A Hierarchical Bayes Model of Primary and Secondary Demand , 1998 .

[14]  Sachin Gupta,et al.  The Recoverability of Segmentation Structure from Store-Level Aggregate Data , 2004 .

[15]  Dick R. Wittink,et al.  Is 75% of the Sales Promotion Bump Due to Brand Switching? No, Only 33% Is , 2003 .

[16]  G. Jin,et al.  The Effect of Prescription Drug Advertising on Doctor Visits , 2005 .

[17]  Dominique M. Hanssens,et al.  Do Promotions Benefit Manufacturers, Retailers, or Both? , 2002, Manag. Sci..

[18]  M. Wosinska,et al.  Just What the Patient Ordered? Direct-to-Consumer Advertising and the Demand for Pharmaceutical Products , 2002 .

[19]  G. Kalyanaram,et al.  Order of Market Entry: Established Empirical Generalizations, Emerging Empirical Generalizations, and Future Research , 1995 .

[20]  Philip Hans Franses,et al.  Optimal Data Interval for Estimating Advertising Response , 2006 .

[21]  Elisabeth Honka,et al.  The effects and role of direct-to-physician marketing in the pharmaceutical industry: an integrative review. , 2005, Yale journal of health policy, law, and ethics.

[22]  R. Chandy,et al.  Sources and Financial Consequences of Radical Innovation: Insights from Pharmaceuticals , 2003 .

[23]  C. Winston,et al.  Direct‐to‐Consumer Advertising and the Demand for Cholesterol‐Reducing Drugs* , 2002, The Journal of Law and Economics.

[24]  Hubert Gatignon,et al.  Order of Entry as a Moderator of the Effect of the Marketing Mix on Market Share , 1996 .

[25]  R. D. Bock,et al.  Marginal maximum likelihood estimation of item parameters , 1982 .

[26]  M S Wilkes,et al.  Direct-to-consumer prescription drug advertising: trends, impact, and implications. , 2000, Health affairs.

[27]  E. Berndt,et al.  Estimation and Hypothesis Testing in Singular Equation Systems with Autoregressive Disturbances , 1975 .

[28]  John D. C. Little,et al.  A Logit Model of Brand Choice Calibrated on Scanner Data , 2011, Mark. Sci..

[29]  Klaus Brockhoff,et al.  A Test for the Product Life Cycle , 1967 .

[30]  Dick R. Wittink,et al.  Decomposing the Sales Promotion Bump with Store Data , 2004 .

[31]  Gregory S. Carpenter,et al.  Consumer Preference Formation and Pioneering Advantage , 1989 .

[32]  D. Kessler,et al.  Demand Effects of Recent Changes in Prescription Drug Promotion , 2003 .

[33]  Donald R. Lehmann,et al.  The Long-Term Impact of Promotion and Advertising on Consumer Brand Choice , 1997 .

[34]  R. Fildes Conditioning Diagnostics: Collinearity and Weak Data in Regression , 1993 .

[35]  David M Levinson,et al.  First Mover Advantages , 2011 .

[36]  Dominique M. Hanssens,et al.  The Category-Demand Effects of Price Promotions , 2000 .

[37]  Sunil Gupta Impact of Sales Promotions on when, what, and how Much to Buy , 1988 .

[38]  Pradeep K. Chintagunta,et al.  Strategic Pricing and Detailing Behavior in International Markets , 2005 .

[39]  M. Hollon Direct-to-consumer marketing of prescription drugs: creating consumer demand. , 1999, JAMA.

[40]  A. Stroud,et al.  Gaussian quadrature formulas , 1966 .

[41]  Cheng Hsiao,et al.  Formulation and estimation of dynamic models using panel data , 1982 .